Article Text

Download PDFPDF
Molecular profiling and targeted inhibitor therapy in atypical chronic myeloid leukaemia in blast crisis

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Handling editor Mary Frances McMullin

  • Contributors SEL performed laboratory studies. CMC, JQ and PTM provided patient care and clinical information. All authors contributed to manuscript preparation and approved the submitted version.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.